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ABSTRACT: Although nitric oxide (NO) is important for cell signaling and nonspecific immunity in the
fruit fly Drosophila melanogaster, little is known about its single NO synthase (dNOS). We expressed
the oxygenase domain of dNOS (dNOSoxy), characterized its spectroscopic, kinetic, and catalytic properties,
and interpreted them in light of a global kinetic model for NO synthesis. Single turnover reactions with
ferrous dNOSoxy showed it could convert Arg to N′ö-hydroxy-L-arginine (NOHA), or NOHA to citrulline
and NO, when it was given 6R-tetrahydrobiopterin and O2. The dNOSoxy catalyzed Arg hydroxylation
and NOHA oxidation at rates that matched or exceeded the rates catalyzed by the three mammalian NOSoxy
enzymes. Consecutive heme-dioxy, ferric heme-NO, and ferric heme species were observed in the NOHA
reaction of dNOSoxy, indicating that its catalytic mechanism is the same as in the mammalian NOS.
However, NO dissociation from dNOSoxy was 4 to 9 times faster than that from the mammalian NOS
enzymes. In contrast, the dNOSoxy ferrous heme-NO complex was relatively unreactive toward O2 and
in this way was equivalent to the mammalian neuronal NOS. Our data show that dNOSoxy has unique
settings for the kinetic parameters that determine its NO synthesis. Computer simulations reveal that
these unique settings should enable dNOS to be a more efficient and active NO synthase than the
mammalian NOS enzymes, which may allow it to function more broadly in cell signaling and immune
functions in the fruit fly.
Nitric oxide synthase enzymes (NOS, EC 1.14.13.39)
convert L-arginine to nitric oxide (NO) and citrulline by
catalyzing a stepwise, NADPH- and O2-dependent reaction
that forms N′ö-hydroxy-L-arginine (NOHA1) as an intermedi-
ate (Scheme 1) (1-3). Three NOS isozymes are expressed
in mammals (neuronal or nNOS, inducible or iNOS, and
endothelial or eNOS), and they differ with regard to their
expression, catalysis, and cellular localization (2, 4-7). All
NOSs comprise attached heme-containing (oxygenase) and
flavin-containing (reductase) domains that are connected by
a central calmodulin (CaM) binding sequence (8-13).
Because NOS oxygenase and reductase domains can fold
and function independently, they have been overexpressed
and subjected to detailed structural, kinetic, and regulatory
studies (14-16), along with some NOS oxygenase-like
enzymes that are present in bacteria (17-19).
The insect Drosophila melanogaster expresses a single
NOS enzyme (dNOS) that participates in the developmental,
behavioral, and host defense pathways of the fruit fly (20-
24). However, besides its generation of NO in a Ca2+- and
CaM-dependent manner (25, 26), similar to the mammalian
eNOS and nNOS enzymes, little is known regarding the
catalytic properties of dNOS. A more detailed characteriza-
tion stands to broaden our understanding of NOS structure-
function relationships and could help to clarify NOS
functions in the fruit fly. To address this, we characterized
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the catalytic and kinetic properties of the dNOS oxygenase
domain (dNOSoxy) after its overexpression in E. coli. Our
results show that dNOSoxy is most similar to the mammalian
nNOS but has kinetic features that distinguish it from the
mammalian NOS enzymes. These findings, along with results
in the accompanying article on the reductase domain of
dNOS, suggest that dNOS evolved to support a more efficient
and active NO release than do the mammalian enzymes.
EXPERIMENTAL PROCEDURES
Materials. All reagents and materials were obtained from
Sigma, Alexis Biochemicals, and Amersham Biosciences,
unless noted otherwise.
dNOSoxy Construct Generation. The pCWori vector
containing the 5′ hexa-His tagged dNOS full-length construct
(4050 bp) within NdeI and HindIII restriction sites, as
described in (26), was used to generate a 5′ hexa-His tagged
construct of the dNOS oxygenase domain and the adjoining
CaM binding sequence (dNOSoxy). This construct ends at
Ser683. To create the stop codon after Ser683, the following
primers were used to amplify a fragment of dNOS: 5′ACG-
GTGGCGCTGAAGATGCAACTGG-3′and5′-GATAAGCTTT-
TACGATTTGCCAGTTTCGGTGGC-3′. The second primer
contains the stop codon in bold followed by the underlined
HindIII restriction site. This PCR product was subcloned into
a PCR-4 vector (Invitrogen) and was digested with BsiWI
(located downstream from the forward primer) and HindIII
(both are unique sites) and cloned into the pCWori plasmid
containing dNOS after it had been digested with the same
enzymes. Positive clones of dNOSoxy were identified by
restriction analysis.
Expression and Purification of dNOSoxy. The dNOSoxy
protein was expressed in recombinant E.coli Rosetta cells
using the pCWori plasmid as done with the mammalian
NOSoxy proteins (34). Transformed bacteria were grown at
37 °C in 3 L of terrific broth supplemented with 100 mg/L
ampicillin. Protein expression was induced when the cultures
reached an OD600 of 0.8 to 1 by adding 1 mM isopropyl-â-
D-thiogalactoside. After further growth at room temperature
for 24 h, the cells were harvested and resuspended in buffer
A (40 mM EPPS, 150 mM NaCl, and 10% glycerol)
containing 1 mM L-Arg, 10 íM H4B, 0.5 mg/mL each of
leupeptin and pepstatin, 1 mg/mL lysozyme, and 1 mM
phenylmethylsulfonyl fluoride. Cells were lysed by freeze-
thawing three times in liquid nitrogen followed by sonication
for five 45-s pulses with a 1-min rest on ice between pulses.
The cell lysate was centrifuged at 4 °C for 30 min, and the
cell-free supernatant was precipitated by adding 50% (w/v)
ammonium sulfate. The precipitant was centrifuged at 4 °C
for 30 min at 16,000 rpm, and was then resuspended in buffer
A containing 5 mM â-mercaptoethanol, 1 mM L-Arg, and
10 íM H4B. The resuspended solution was loaded onto a
Ni-NTA-Sepharose CL-4B column that had been charged
with 50 mM NiSO4 and equilibrated with buffer A containing
5 mM â-mercaptoethanol, 1 mM L-Arg, and 10 íM H4B.
The column was washed with 5 volumes of equilibration
buffer and 5 volumes with equilibration buffer containing
10 mM imidazole. The dNOSoxy protein was eluted with
100 mM imidazole in buffer A. The eluted protein sample
was dialyzed against buffer B (40 mM EPPS and 10%
glycerol) and then run onto a Q-Sepharose column equili-
brated with buffer B containing 1 mM L-Arg and 10 íM
H4B. The bound protein was washed extensively with the
equilibration buffer containing increasing concentrations of
NaCl, and the bound protein was eluted with Buffer B
containing 200 mM NaCl plus L-Arg and H4B. The resulting
protein sample was concentrated, dialyzed to remove the
imidazole, and finally stored frozen in aliquots at -80 °C.
UV-visible spectra of diluted protein samples were
recorded on an Hitachi U3110 spectrophotometer in the
absence or presence of 20 íM H4B and 1 mM Arg. Enzyme
concentration was quantified using the absorption of the
ferrous-CO adduct at 444 nm and an extinction coefficient
of 74 mM-1cm-1 (A444 - A500).
Preparation of Ferrous dNOSoxy. Concentrated dNOSoxy
was placed in a cuvette and made anaerobic by several cycles
of evacuation and purging with deoxygenated N2. An
anaerobic solution that contained 50 mM EPPS at pH 7.5,
H4B, and L-Arg or NOHA was then added. The enzyme was
reduced by the sequential addition of a dithionite solution
from which the concentration was standardized against
ferricyanide. The heme reduction was monitored spectro-
photometrically. The reduced enzyme solution was trans-
ferred into a syringe in a stopped-flow instrument using a
gastight syringe.
Stopped-Flow Single Catalytic TurnoVer Reactions. Rapid-
Scanning stopped-flow experiments were performed at
10 °C using a HI-TECH SF-61 instrument equipped with a
HI-TECH MG-6000 rapid-scanning diode-array detector, as
described previously (30, 34, 36). An anaerobic solution
containing 50 mM EPPS (pH 7.5), 10 íM ferrous dNOSoxy,
10 íM H4B, and either 1 mM L-Arg or 0.5 mM NOHA was
rapidly mixed with an equal volume of air-saturated buffer
(50 mM EPPS at pH 7.5). Ninety-six scans from 350 to
700 nm were collected within 0.0018 to 2 s after each mixing.
Sequential spectral data were fit to different reaction models
using the Specfit global analysis program (provided by Hi-
Tech Ltd.), which can calculate the number of different
enzyme species, their spectra, and their concentrations versus
time during the single turnover reactions. Data from six to
eight sequential reactions were averaged to obtain the final
traces.
Product Stoichiometry Analyses. Amino acids in aliquots
taken from single turnover reactions were derivatized with
o-phthalaldehyde and then analyzed by reverse-phase HPLC
with fluorescence detection (27). Samples were filtered
through an Amicon Centricon device (10,000 MW cutoff)
prior to derivatization. Samples were injected onto a Hewlett-
Packard ODS-Hypersil column that was equilibrated with
5 mM ammonium acetate at pH 6.0 and 20% methanol and
then subjected to an increasing gradient of methanol.
Retention times and concentrations of amino acids were
calculated on the basis of NOHA and citrulline standard
solutions.
NO Binding Kinetics of Ferric NOSoxy Enzymes. The
experiments were performed as previously described (51).
An anaerobic solution containing 2 íM of either dNOSoxy
or nNOSoxy, 1 mM Arg, 50 íM H4B, 0.5 mM EDTA in
40 mM EPPS at pH 7.6 was rapidly mixed at 10 °C in the
stopped-flow instrument with a buffered solution containing
different concentrations of NO. The NO solutions were made
by diluting a buffered, NO-saturated solution in anaerobic
buffer and assuming a NO concentration of 1.9 mM for a
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saturated solution at 25 °C. Six to eight sequential reactions
were run at each NO concentration and then averaged to
obtain the final traces. Data were fit to a single or double
exponential equation.
Ferrous Heme-NO Oxidation Rate. A solution of 8 íM
ferric dNOSoxy in a 40 mM EPPS buffer (pH 7.6),
containing 1 mM Arg, 50 íM H4B, and 0.5 mM EDTA,
was made anaerobic in a sealed cuvette and reduced by
adding a small amount of anaerobic sodium dithionite
solution at 10 °C. To minimize adding excess dithionite,
titration of the ferric enzyme was stopped as soon as the
heme became reduced, as judged by a shift in the Soret
absorbance and the disappearance of absorbance at 650 nm.
NO was subsequently added from a NO-saturated solution.
The ferrous heme-NO enzyme was transferred to the
stopped-flow instrument and mixed at 10 °C with buffer
containing various O2 concentrations and 40 mM EPPS (pH
7.6), 1 mM Arg, 50 íM H4B, and 0.5 mM EDTA. The
kinetics of ferrous heme-NO oxidation was determined from
the absorbance loss at 438 nm (ferrous heme-NO decay)
and buildup at 396 nm (ferric heme buildup). Traces at both
wavelengths were averaged from 6 to 10 individual reactions
and were fit to a single-exponential function using software
provided by the instrument manufacturer.
Computer Simulation of the Global Kinetic Model for NOS
Catalysis. Simulations of the model in Figure 6 were done
using kinetic values determined here or previously at 10 °C
and by using Mathcad software as previously described in
detail (31, 44, 50). In the current simulations, the following
parameter values were utilized: for dNOS, kcat1 28 s-1, kcat2
48 s-1, kd 18 s-1, and kox 0.2 s-1; for nNOS (38), kcat1
18 s-1, kcat2 29 s-1, kd 5 s-1, and kox 0.2 s-1. The heme
reduction rate (kr) was varied as described in the text, and
we assumed a constant concentration of O2 (140 íM) and
NADPH (40 íM) and no buildup of NO in solution.
RESULTS AND DISCUSSION
Expression, Purification, and Spectral Properties. The
oxygenase domain of the Drosophila melanogaster NO
synthase (dNOSoxy) was overexpressed in E. coli BL21
Rosetta cells. The dNOSoxy protein had a His6 tag at its
N-terminus to enable purification by nickel-nitriloacetic acid
sepharose column chromatography. The average yield of
purified dNOSoxy was 3 to 4 mg/L of culture, and the final
protein was approximately 90% homogeneous as judged by
the SDS-PAGE analysis (data not shown). The apparent
molecular mass of the dNOSoxy was 76 kDa, which is in
good agreement with the predicted size of the polypeptide
based on the gene sequence.
Purification of dNOSoxy was done in the presence of
L-Arg and H4B. The UV-visible spectrum of dNOSoxy
showed a Soret peak at 396 nm (Figure 1), typical of
mammalian NOS enzymes containing bound Arg and H4B
(27, 28) and of five-coordinate, high-spin heme-thiolate
proteins in general. Reduction of dNOSoxy with dithionite
caused the Soret band to shift to 414 nm (not shown), and
subsequent addition of CO shifted the Soret band to 445 nm
(Figure 1), confirming an intact heme-thiolate bond in
dNOSoxy.
Single Catalytic TurnoVer Reactions of dNOSoxy. We
utilized rapid-scanning stopped flow spectroscopy to docu-
ment heme transitions during the Arg hydroxylation and
NOHA oxidation reactions catalyzed by dNOSoxy. This
approach has been quite valuable for understanding the
reaction mechanism and kinetics of the mammalian NOS
enzymes (29-31). Dithionite-reduced (ferrous) dNOSoxy
that contained H4B and either Arg or NOHA was rapidly
mixed at 10 °C with an O2-saturated buffer to initiate the
reaction.
For the Arg single turnover reaction, prior work with
mammalian NOSoxy enzymes showed that a heme-dioxy
intermediate is formed upon mixing reduced enzyme with
O2-containing buffer, and then this species converts to ferric
NOSoxy concurrent with Arg hydroxylation to form NOHA
(30-32). However, in the Arg hydroxylation reaction of
dNOSoxy, we observed no clear buildup of a heme-dioxy
intermediate prior to the formation of ferric dNOSoxy (Figure
2). Global analysis of the spectral data also failed to indicate
a clear buildup of a heme-dioxy intermediate in the reaction.
This contrasts with the three mammalian NOSoxy enzymes,
which typically build up a detectable heme-dioxy intermedi-
ate with characteristic heme Soret absorbance near 427 nm
FIGURE 1: UV-visible spectra of purified dNOSoxy. Scan A is
ferric dNOSoxy in the presence of L-Arg and H4B, while scan B is
the ferrous heme-CO complex.
FIGURE 2: Kinetics of heme transitions during Arg oxidation by
dNOSoxy under single turnover conditions. Anaerobic ferrous
dNOSoxy containing Arg and H4B was mixed at 10 °C with air-
saturated buffer in the stopped flow instrument to start the reaction.
The upper panel contains spectral traces collected during the
reaction and show the direction of absorbance change. The lower
panel shows the absorbance change over time at two wavelengths.
Data are representative of four independent experiments.
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during the Arg hydroxylation reaction (29-32). Despite this,
the shifting isosbestic points in Figure 2A and the biphasic
absorbance change at 396 nm in Figure 2B do suggest the
formation of an intermediate in the reaction. Because the
maximally shifted spectrum is centered at 420 nm in Figure
2A, it is possible that the dNOSoxy heme-dioxy intermediate
formed in the Arg reaction is the 420 nm species that is
observed for mammalian NOS enzymes under some condi-
tions (52). In any case, we still could estimate the rate of
Arg hydroxylation catalyzed by dNOSoxy from the concur-
rent loss of absorbance at 426 nm and the gain of absorbance
at 396 nm (equivalent to the rate of ferric dNOSoxy
formation) (Figure 2). The rates estimated at the two
wavelengths were similar (29 s-1 and 26 s-1, respectively).
These rates are in the high range of rates obtained for the
heme-dioxy to ferric heme transition that is associated with
Arg hydroxylation by the mammalian NOSoxy enzymes,
which range from 6 to 24 s-1 under identical reaction
conditions (37). Thus, dNOSoxy appears to catalyze Arg
hydroxylation as fast or faster than most mammalian NOS
enzymes and is most similar to nNOS in this respect.
Amino acid product analysis confirmed that dNOSoxy
generated NOHA from Arg in the single turnover reactions
(0.3 NOHA per heme). This product yield is within the range
reported for Arg hydroxylation by mammalian NOSoxy
enzymes under similar reaction conditions (0.2 to 0.8 NOHA
per heme) (32, 34, 35).
For the NOHA single turnover reaction of dNOSoxy,
global analysis of the rapid scanning data indicated four
consecutive heme species, which, on the basis of previous
work with mammalian NOSoxy enzymes (36, 37), could be
identified as the starting ferrous dNOSoxy, a transient heme-
dioxy intermediate, a ferric heme-NO intermediate, and the
ferric dNOSoxy product. Thus, three observable transitions
occurred during the NOHA oxidation reaction, where k1, k2,
and k3 are the calculated rates for the transitions:
Figure 3 illustrates the UV-visible spectrum of the four
enzyme species and the time course of their consecutive
appearance and/or disappearance. The Soret absorbance
peaks for the dNOSoxy FeII, FeIIIO2-, FeIIINO, and FeIII heme
species were 415, 424, 438, and 396 nm, respectively, which
closely match the absorbance positions of these same species
in mammalian NOSoxy enzymes when they catalyze NOHA
oxidation (34, 36). Why a 428 nm ferrous-dioxy species was
clearly observable in the NOHA reaction but not in the Arg
reaction is puzzling and deserves further investigation. Our
NOHA single turnover data imply that dNOS has a similar
if not identical mechanism of catalysis compared to the
mammalian enzymes. Amino acid product analysis confirmed
that dNOSoxy generated citrulline from NOHA in the single
turnover reactions (0.4 NOHA per heme), consistent with
our observation of a buildup of a ferric heme-NO product
complex during the reaction.
The calculated rates for the heme transitions observed
during NOHA oxidation by dNOSoxy are listed in Table 1,
along with values obtained for NOHA reactions catalyzed
by the three mammalian NOSoxy enzymes and by one
bacterial NOSoxy protein under identical or nearly identical
reaction conditions (17, 34, 36, 38). The comparison shows
that dNOSoxy has a rate of product formation as measured
by the k2 transition (also designated kcat) that is as fast or
faster than that in the mammalian and bacterial NOS enzymes
(30, 36). The greatest difference, however, appears to be in
the k3 transition, which is the macroscopic dissociation rate
(kd) of the ferric heme-NO product complex that forms at
the end of each catalytic cycle in all NOS enzymes examined
to date (31). This kd is important because it helps to determine
what percentage of the NO synthesized by a NOS enzyme
is actually released into solution (39). Remarkably, the kd
values derived from our NOHA single turnover experiments
indicate that NO dissociation from ferric dNOSoxy is 3 to 8
times faster than NO dissociation in the mammalian NOS
enzymes and is 90 times faster than that in the bacterial NOS
(Table 1).
To confirm whether dNOSoxy has a faster NO dissociation
than the mammalian enzymes, we utilized a different stopped
flow method (51) to compare the NO binding kinetics of
ferric dNOSoxy and nNOSoxy. Each enzyme was mixed
under pseudo-first-order conditions with solutions that
contained different concentrations of NO, and the observed
NO binding rates were plotted versus the initial NO
concentration (Figure 4). A slight deviation from a single-
exponential fit was observed (particularly for the dNOSoxy
FeII 98
k1
FeIIIO2
- 98
k2
FeIIINO 98
k3
FeIII
FIGURE 3: UV-visible spectra of heme species detected and their
transition kinetics during NOHA oxidation by dNOSoxy under
single turnover conditions. Anaerobic ferrous dNOSoxy containing
NOHA and H4B was mixed at 10 °C with air-saturated buffer in
the stopped flow instrument to start the reaction. The upper panel
contains spectra of four species derived from global analysis of
the data. These in order of appearance are the ferrous (a, solid line),
heme-dioxy (b, dotted line), ferric heme-NO (c, dashed line), and
ferric (d, dash-dotted line) forms of dNOSoxy. The lower panel
shows the kinetics of disappearance or formation of each spectral
species. Line patterns for each species are the same as those in the
upper panel. Data are an average of 6 to 10 reactions and are
representative of four independent experiments.
11860 Biochemistry, Vol. 46, No. 42, 2007 Ray et al.
reactions), and therefore, for the sake of comparison both
the nNOSoxy and dNOSoxy data were fit to a biexponential
equation. The slower phase (k2) contributed 30% or less of
the total absorbance change in all cases and appeared to be
independent of NO concentration (Figure 4), whereas the
fast phase (k1) was NO concentration-dependent. The y axis
intercepts of the k1 rate data provide an estimate of the NO
kd for each ferric enzyme and are 21.0 ( 5.5 and 57.9 (
3.8 s-1 for dNOSoxy and nNOSoxy, respectively. These data
are consistent with our NOHA single turnover experiments
and confirm that ferric dNOSoxy has a faster NO kd than
the mammalian NOS enzymes.
In bacterial NOSoxy, we know that a Ile/Val substitution
near the entrance to the heme pocket is partly responsible
for its slow NO dissociation from the ferric heme (39).
However, a protein sequence comparison (Figure S1, Sup-
porting Information) reveals no obvious differences in the
residues near the heme pockets of dNOSoxy and mammalian
NOSoxy enzymes. This implies that the general dimensions
and composition of the dNOSoxy heme pocket are similar
to those in the mammalian NOSoxy enzymes (28, 39-41).
Thus, faster NO dissociation from the dNOSoxy ferric heme
could be due to other more global effects.
A second kinetic parameter that helps determine NOS
catalytic behavior is the oxidation rate of the enzyme ferrous
heme-NO complex. This complex forms whenever the ferric
heme-NO product complex becomes reduced during steady-
state turnover in the full-length NOS enzymes (42-44). We
studied this reaction in dNOSoxy by mixing the ferrous
heme-NO complex with oxygenated buffer at 10 °C in a
stopped-flow spectrometer equipped with a diode-array
detector. Figure 5, panel A shows the spectrum of authentic
ferric, ferrous, and ferrous-NO forms of dNOSoxy. Panel B
contains a group of consecutive spectral scans collected
during a typical reaction. The several isobestic points indicate
that a monophasic transition occurs between the starting
ferrous heme-NO complex of dNOSoxy and the ending
ferric enzyme, as is also reported for the reaction catalyzed
by mammalian NOSoxy enzymes (38, 44). The rates of
heme-NO complex disappearance and ferric enzyme forma-
tion were determined from the absorbance changes at 438
nm and at 396 nm, respectively, and were best fit as
monophasic transitions (Figure 5C). At the half air-saturated
condition used here (O2 concentration 140 íM), the
oxidation rate of the dNOSoxy ferrous heme-NO complex
(designated kox) was 0.093 s-1 at 10 °C. This rate is similar
to that of the ferrous heme-NO complex of nNOSoxy at
the same O2 concentration and temperature (0.1 to 0.2 s-1)
but is 6 and 13 times slower than the kox rates measured for
Table 1: Observed Rates of Heme Transitions during NOHA Single Turnover Reactions Catalyzed by Various NOSoxy Enzymesa
transformations dNOSoxyb iNOSoxyc nNOSoxyd eNOSoxye bsNOSf
heme-dioxy formation (k1)g 157 ( 15 47 ( 4 129 ( 5 NA 29 ( 1
heme-dioxy disappearance or
FeIII-NO formation (k2, kcat)
48 ( 3 37 ( 1 29 ( 1 18 7 ( 1
FeIII-NO disappearance or
ferric heme formation (k3, kd)
18 ( 2 2.3 ( 0.1 5 ( 1 3 0.2 ( 0.1
a The rates were determined at 10 °C and are the mean ( SD. b This work. c Wei et al., ref 36. d Panda et al., ref 38. e Unpublished observations.
f Adak et al., ref 17. g Rates were recorded in a half O2-saturated reaction except for iNOSoxy and bsNOSoxy, which were recorded in a half
air-saturated reaction. NA, not available.
FIGURE 4: Kinetics of NO binding to dNOSoxy and nNOSoxy.
An anaerobic solution of either ferric enzyme was mixed with NO
containing solution in a stopped-flow spectrophotometer at 10 °C
and the ferric heme-NO complex formation was monitored at
438 nm. The absorbance traces were fit to a biexponential equation,
and the observed rates are plotted vs the NO concentration with
the least-squares lines of best fit as indicated. The data are
representative of two independent experiments.
FIGURE 5: Oxidation of the dNOSoxy ferrous heme-NO complex.
Panel A shows the UV-visible spectra of the ferric, ferrous, and
ferrous-NO forms of dNOSoxy. Panel B contains spectral traces
collected within 58 s after mixing the dNOSoxy ferrous heme-
NO complex with air-saturated buffer in the stopped flow instrument
at 10 °C. Arrows indicate the direction of absorbance change with
time. Panel C shows the absorbance changes at 438 and 496 nm
vs time during the reaction of the dNOSoxy ferrous heme-NO
complex with air-saturated buffer. Panel D plots the kobs values
calculated from the absorbance changes at either wavelength for
reactions that were performed at the different indicated concentra-
tions of O2. The least-squares line of best fit is indicated. Data are
the average of 6 to 10 individual reactions and are representative
of three similar experiments.
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the ferrous heme-NO complexes of eNOSoxy and iNOSoxy,
respectively (44, 45).
We went on to measure kox rates of dNOSoxy at various
O2 concentrations. The rates we obtained are plotted in Figure
5D. The slope gives a second-order rate constant for the
reaction of 290 M-1 s-1. This value is quite similar to that
obtained for mammalian nNOSoxy, whose kox second-order
rate constant is 220 M-1 s-1 at 10 °C (unpublished data).
We conclude the ferrous heme-NO complex of dNOSr is
relatively un-reactive toward O2 and in this way is similar
to nNOSoxy.
Implications for the NO Synthesis ActiVity of dNOS. Our
results provide two (kd, kox) of the three kinetic parameters
that allow one to model and understand the catalytic behavior
of any given NOS (31, 44). The third variable is the heme
reduction rate (kr), which cannot be obtained using the
isolated oxygenase or reductase domains of dNOS. However,
even without a measured kr value, we can still make
reasonable predictions about the catalytic behavior of dNOS.
Our data show that dNOS has a relatively fast kcat and a slow
kox like nNOS. It also has a reductase domain whose electron-
transfer properties and regulation (see the accompanying
article) are similar to those of the nNOS reductase domain
(46, 47, 48). However, there is an important difference
regarding the kd values of ferric dNOS and nNOS that will
distinguish their catalytic behaviors. For example, in nNOS,
the rates of heme reduction (kr, 3 to 4 s-1) and NO
dissociation (kd, 5 s-1) are similar (34, 43). This causes its
ferric heme-NO product complex to partition in about a 2:3
ratio between futile and productive cycles during catalysis
(Figure 6A). Because nNOS has a relatively slow kox (0.2
s-1), a significant proportion of enzyme molecules ac-
cumulate as the ferrous heme-NO complex during steady-
state NO synthesis (31, 44). This in turn compromises the
observed NO synthesis activity of nNOS and greatly
increases its apparent KmO2, enabling NOS to have a very
gradual and near linear oxygen-NO synthesis activity re-
sponse across the entire physiologic O2 concentration range
(31, 49, 50). In comparison, dNOS has a 5-times faster NO
dissociation (kd is 18 s-1) that will predispose its ferric
heme-NO product complex to release NO rather than
become reduced to the ferrous heme-NO complex (Figure
6A). This means that at the heme reduction rate measured
for nNOS (approximately 4 s-1), the kd of dNOS would allow
four enzyme molecules to release NO for every one molecule
that enters the futile cycle and therefore should enable dNOS
to have a greater NO synthesis activity than nNOS.
How the different kd values will impact the catalytic
behavior of dNOS and nNOS can be determined by computer
simulation of the global kinetic model in Figure 6A (44, 50)
using the kinetic values we have measured for dNOSoxy
and nNOS (44, 50). We performed such simulations using
the measured kd values of 18 and 5 s-1 for dNOS and nNOS,
respectively, a common kox value of 0.2 s-1, and heme
reduction rates (kr) ranging from 0.3 to 12 s-1, which cover
and exceed the known kr values for NOS enzymes. Our
simulations indicate that a smaller proportion of dNOS would
exist as a ferrous heme-NO complex during the steady state
compared to that of nNOS (Figure 6B). Moreover, dNOS
would be up to 3.5 times more active than nNOS over the
range of heme reduction rates (Figure 6C). Thus, a unique
blend of kinetic parameters is likely to enable dNOS to be
a more active and efficient NO synthase than mammalian
nNOS, while still allowing other important catalytic behav-
iors of the two enzymes (Ca2+ concentration-activity
response, KmO2 for NO synthesis) to remain similar. That
dNOS would have a higher NO release capacity plus the
regulatory mechanisms of a constitutive mammalian NOS
(nNOS) makes some sense because Drosophila evolved to
express a single NOS for both its cell signaling and host
FIGURE 6: Global kinetic model for NOS catalysis and results
derived from model simulations. Panel A shows that ferric enzyme
reduction (kr) is rate-limiting for the biosynthetic reactions (central
linear portion). kcat1 and kcat2 are the conversion rates of the FeIIO2
species to products in the Arg and NOHA reactions, respectively.
The ferric heme-NO product complex (FeIIINO) can either release
NO (kd) in the productive cycle or become reduced (kr′) to a ferrous
heme-NO complex (FeIINO), which reacts with O2 (kox) to
generate nitrate and ferric enzyme in the futile cycle. Panel B shows
the calculated dNOS and nNOS enzyme distributions during steady-
state NO synthesis at a common heme reduction rate of 3 s-1. Panel
C plots the steady-state NO release rates as a function of kr for
dNOS and nNOS. Activities were calculated by simulation of the
global kinetic model using parameters derived from dNOSoxy and
nNOS. See Experimental Procedures for details.
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defense, while mammals utilize a different NOS for each
purpose.
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